Benzydamine inhibits osteoclast differentiation and bone resorption via down-regulation of interleukin-1β expression

Bone diseases such as osteoporosis and periodontitis are induced by excessive osteoclastic activity, which is closely associated with inflammation. Benzydamine (BA) has been used as a cytokine-suppressive or non-steroidal anti-inflammatory drug that inhibits the production of pro-inflammatory cytoki...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Han Saem, Lee, Jiae, Lee, Hye In, Kim, Narae, Jo, You-Jin, Lee, Gong-Rak, Hong, Seong-Eun, Kwon, Minjeong, Kim, Nam Young, Kim, Hyun Jin, Park, Jin Ha, Lee, Soo Young, Jeong, Woojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049613/
https://www.ncbi.nlm.nih.gov/pubmed/32140392
http://dx.doi.org/10.1016/j.apsb.2019.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049613/
https://www.ncbi.nlm.nih.gov/pubmed/32140392
http://dx.doi.org/10.1016/j.apsb.2019.11.004

Ejemplares similares